WC
RMD icon

Whitney & Co’s ResMed RMD Stock Holding History

Whitney & Co’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.55M Buy
49,013
+165
+0.3% +$34.2K 0.7% 42
2026
Q1 		$11M Sell
48,848
-133
-0.3% -$33.1K 0.91% 36
2025
Q4 		$11.8M Sell
48,981
-547
-1% -$140K 0.94% 35
2025
Q3 		$13.6M Sell
49,528
-4,003
-7% -$1.09M 1.23% 24
2025
Q2 		$13.8M Buy
53,531
+1,043
+2% +$249K 1.36% 24
2025
Q1 		$11.7M Buy
52,488
+1,496
+3% +$349K 1.25% 27
2024
Q4 		$11.7M Sell
50,992
-6,463
-11% -$1.56M 1.22% 28
2024
Q3 		$14M Buy
57,455
+1,111
+2% +$248K 1.5% 25
2024
Q2 		$10.8M Buy
56,344
+25,376
+82% +$5.15M 1.24% 29
2024
Q1 		$6.13M Buy
30,968
+2,099
+7% +$385K 0.73% 45
2023
Q4 		$4.97M Buy
+28,869
New +$4.44M 0.64% 46
2018
Q4 		– Sell
-175
Closed -$19K – 375
2018
Q3 		$19K Buy
+175
New +$19.2K ﹤0.01% 250

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Whitney & Co's RMD Position: Q2 2026 in Review

Whitney & Co increased its ResMed (RMD) stake by 0.34% in Q2 2026, buying an estimated $34.2K and bringing the position to 49,013 shares worth $9.55M. The position accounts for 0.7% of the portfolio, ranked #42.

Whitney & Co first reported a position in RMD in Q3 2018 and has held it in 12 quarters since. The position peaked at $14M in Q3 2024. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Whitney & Co held 49,013 shares of ResMed worth $9.55M as of Q2 2026.
  • Whitney & Co bought 165 ResMed shares in Q2 2026, an estimated $34.2K.
  • ResMed made up 0.7% of Whitney & Co's portfolio in Q2 2026, its #42 holding.
  • Whitney & Co first reported a position in ResMed in Q3 2018 and has held it in 12 quarters since.
  • Whitney & Co's ResMed position peaked at $14M in Q3 2024.
  • 888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Whitney & Co's 13F filing for Q2 2026, filed 28 Jul 2026.